Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1 Psychological Well-Being 1 Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1

Interventions

Paclitaxel 20 Gemcitabine 16 Dexamethasone 16 Bevacizumab 16 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Fluorouracil 11 Leucovorin 10 Cisplatin 10 pembrolizumab 9 Prednisone 9 Pemetrexed 9 Epoetin Alfa 9 venetoclax 8 atezolizumab 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Fish Oils × Clear all

NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting

25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡